What is SEMAGLUTIDE 3mg (30 Tablets)
Semaglutide is an incretin-pathway peptide studied as a selective GLP-1 receptor agonist for effects on appetite regulation, gastric emptying, and glycemic control in controlled laboratory models.
Potential Research Effects
• Appetite regulation and satiety-signaling exploration (GLP-1)
• Glucose control, insulin-sensitivity, and β-cell pathway studies
• Gastric emptying kinetics and post-prandial glycemia models
• Lipid metabolism and adiposity reduction research
• Body-composition and weight-management paradigms
Includes 30 research-use tablets per unit.
Cybergen Peptides: Research Use Disclaimer
All products offered by Cybergen Peptides are intended solely for laboratory, educational, and scientific research purposes.
These materials are supplied for in-vitro research only (“in glass”) and are
not intended for human or animal consumption, medical use, or diagnostic applications.
Cybergen Peptides compounds are not drugs, medicines, or dietary supplements and have
not been evaluated or approved by the U.S. Food and Drug Administration (FDA) or any other regulatory agency.
They are not intended to diagnose, treat, cure, or prevent any disease.
Any form of bodily introduction, clinical testing, or therapeutic application is strictly prohibited.
